CHEMICAL/BIOLOGICAL DEFENSE (SDD)

Abstract

Operational forces have an immediate need to survive, safely operate, and sustain operations in a chemical and biological agent threat environment across the continuum of global, contingency, special operations/low-intensity conflict, counter-narcotics, and other high risk missions. Operating forces have a critical need for defense against worldwide proliferation of Chemical and Biological (CB) warfare capabilities and for medical treatment of casualties in medical treatment facilities. Congress has directed centralized management of Department of Defense (DoD) CB Defense initiatives, both medical and non-medical. This program element supports the System Development and Demonstration (SDD) of CB defensive equipment, both medical and non-medical. These projects have been restructured to consolidate Joint- and Service-unique tasks within four commodity areas: contamination avoidance; force protection (individual and collective); decontamination; and medical countermeasures. The consolidation will provide for development and operational testing of equipment for Joint Service,as well as, Service-unique requirements. Contamination avoidance efforts under this system development program will provide U.S. forces with real-time hazard assessment capabilities. They include advanced multi-agent point and remote chemical detection systems for ground, aircraft, and shipboard applications; automated warning and reporting systems; integrated radiation detection and monitoring equipment; and enhanced battlefield reconnaissance capabilities. Force protection efforts will increase protection levels while decreasing physical and psychological burdens imposed by protective equipment. They include improved aircrew respiratory protection, lightweight integrated suit technology, and shipboard collective protection equipment. The medical chemical defense system development program funds improved medical equipment and drugs essential to counteracting lethal and performance-degrading effects of chemical threats and medical equipment essential to meeting medical requirements on the integrated battlefield with emphasis on decreased size/weight and high mobility, yet supporting large numbers of combat casualties. Additionally, foreign medical materiel may be procured for exploitation of advanced technology and development to meet medical defense goals. This program element supports the development of prophylactic and therapeutic drugs and rapid identification and diagnostic systems. DoD Biological Defense mission requires the detection of validated biological threat agents to provide early warning capabilities on mobile and fixed platforms. This program element will provide theater protection through the development of point and stand-off detection systems. The detection system concept will provide detection, identification, warning, and sample collection for verification that a biological agent attack has occurred. This program element also provides for the development of biological defense medical programs. DoD Biological Defense medical mission will address: (1) Protective vaccines - vaccination capability against the most probable biological threat agents; (2) Identification - clinical identification of biological threat agents through medical evaluation and laboratory analysis to augment early warning capabilities. CBDP reprioritization does not continue program efforts into Fiscal Year 2012 for the following programs: Medical Radiological Countermeasures (MRADC), Inhalational Atropine (IA) and the Joint Service Sensitive Equipment Decontamination (JSSED) programs. Additionally, the BA5 reductions in support of the DoD Efficiency Initiatives for FY12 include: PD TESS efforts reduced in association with program changes (-$3.306M); Major Defense Acquisition Program support (-$2.259M); Program management support reduced (-$3.304M); Service Support Contracts reduced (-$4.025M). The projects in this program element support efforts in the system development phases of the acquisition strategy and are therefore correctly placed in Budget Activity 5.

Open PDF

Document Details

Document Type
R2 Budgetary Justification
Publication Date
Oct 01, 2012
Source ID
0604384BP_5_0400_PB_2012
Change Summary Explanation
Funding: FY10 - Realignment between BA4 and BA5 for approved threshold reprogramming to meet FAR guidelines (-$2,000K CA5; -$5,666K CM5; -$12,455K DE5; -$2,305K IP5; -$14,714K IS5; -$6,898K MC5); Other program realignments to support CBDP and DoD program initiatives (-$7,707K CA5; -$6,771K DE5; +$1,300 IP5; +$5,200K IS5; +$751K MB5; -$2,823K MC5; -$8,168K MR5; +$3,240K TE5); SBIR Transfer (-$952K CA5; -$111K CM5; -$155K CO5; -$365K DE5; -$241K IP5; -$3522K IS5; -$746K MB5; -$180K MC5; -$108K MR5; -$461K TE5). FY12 - Adjustments less than 10% of total program. Schedule: N/A Technical: N/A
Service Agency Name
Chemical and Biological Defense Program

Tags

Communities of Interest

  • Biomedical

DTIC Thesaurus Topics

  • Business Administration
  • Chemical Warfare
  • Chemical Warfare Agents
  • Control Systems
  • Detectors
  • Health Services
  • Information Exchange
  • Information Systems
  • Management Personnel
  • Medical Personnel
  • Organizational Structure
  • Program Management
  • Software Testing
  • Systems Engineering
  • Test And Evaluation
  • Therapy
  • Warning Systems

Readers

  • Critical Infrastructure Protection in CBRN and WMD Threats.

Technology Areas

  • Biotechnology

Related Documents